Paspat診断液(100倍液)の皮内反応の基礎的研究
1963 年 12 巻 3-4 号 p. 131-133,136
詳細
1963 年 12 巻 3-4 号 p. 131-133,136
Resulted from cutaneous injection made trially with the diagnosis solution of Paspat (1/l00 solution) in the healthy person group (202 persons), bronchial asthmatic group (35 persons), and antiallergic disorder group (13 persons), the positive rate of the healthy group was quite low (wheal l% and erythemata 2%), but that of the asthmatic group showed 11% on wheal and 29% on erythemata, that is, Paspat indicated to have a tendency to be easily causable to the positivity in the asthmatic, who had a strong infectious factor. Consequently, in case the positivity of Paspat diagnosis solution has a concern with Paspat treatment, it is surmised as effectiveness in the asthmatic, who gets stronger the infectious factor than the inhalation factor. In conclusion, the author expresses our gratitude to Prof. Yoshio Oshima for his kind guidance and revise.
